Cargando…
Design and Synthesis of Highly Potent and Isoform Selective JNK3 Inhibitors: SAR Studies on Aminopyrazole Derivatives
[Image: see text] The c-jun N-terminal kinase 3 (JNK3) is expressed primarily in the brain. Numerous reports have shown that inhibition of JNK3 is a promising strategy for treatment of neurodegeneration. The optimization of aminopyrazole-based JNK3 inhibitors with improved potency, isoform selectivi...
Autores principales: | Zheng, Ke, Iqbal, Sarah, Hernandez, Pamela, Park, HaJeung, LoGrasso, Philip V., Feng, Yangbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266361/ https://www.ncbi.nlm.nih.gov/pubmed/25393557 http://dx.doi.org/10.1021/jm501256y |
Ejemplares similares
-
Correction to Design
and Synthesis of Highly Potent
and Isoform Selective JNK3 Inhibitors: SAR Studies on Aminopyrazole
Derivatives
por: Zheng, Ke, et al.
Publicado: (2016) -
Structural Basis and Biological Consequences for JNK2/3 Isoform Selective Aminopyrazoles
por: Park, HaJeung, et al.
Publicado: (2015) -
Thiophene-Pyrazolourea Derivatives as Potent, Orally
Bioavailable, and Isoform-Selective JNK3 Inhibitors
por: Feng, Yangbo, et al.
Publicado: (2020) -
Approaches towards the synthesis of 5-aminopyrazoles
por: Aggarwal, Ranjana, et al.
Publicado: (2011) -
SAR Studies of 5-Aminopyrazole-4-carboxamide
Analogues as Potent and Selective Inhibitors of Toxoplasma
gondii CDPK1
por: Huang, Wenlin, et al.
Publicado: (2015)